Taizhou Mabtech Pharmaceutical Co.,ltd
Clinical trials sponsored by Taizhou Mabtech Pharmaceutical Co.,ltd, explained in plain language.
-
Can a new drug boost chemotherapy for head and neck cancer?
Disease control Not yet recruitingThis trial tests whether adding an experimental drug called Enlituo to a standard chemotherapy combination helps people with advanced, recurrent, or metastatic head and neck squamous cell carcinoma. Participants receive either the standard combination (Anyouping plus platinum-bas…
Phase 2/3 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug combo aims to match standard care in colorectal cancer battle
Disease control Not yet recruitingThis phase 3 study tests whether a new drug called Enlituo, combined with chemotherapy (FOLFOX), works as well as the standard treatment Erbitux plus FOLFOX for people with advanced colorectal cancer that has specific genetic traits (RAS/BRAF wild-type and MSS/pMMR). About 608 ad…
Phase 3 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC